Article

Prediction of Covid-19 vaccine effectiveness in adult populations and in clinically-vulnerable subgroups

2022-11-25

Abstract excerpt

Predictions of Covid vaccine effectiveness could support rapid and effective measures against the pandemic. Our modelling boosts the accuracy and applications of these predictions, especially to subgroups. We model the symptomatic effectiveness of Comirnaty or Vaxzevria with 50% neutralising antibody titres from a large UK immunogenicity study and with up to 68 effectiveness estimates from 23 vaccine studies. We p...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 554e026e-1f49-5c34-b434-a73396e31c65
DOI: 10.1101/2022.11.22.22282637

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Prediction of Covid-19 vaccine effectiveness in adult populations and in clinically-vulnerable subgroupsDOI 10.1101/2022.11.22.22282637Read

Predicting immune protection against outcomes of infectious disease from population-level effectiveness data with application to COVID-19Semantic proximity Read

Vaccine effectiveness and duration of protection of Comirnaty, Vaxzevria and Spikevax against mild and severe COVID-19 in the UKSemantic proximity Read

The Effectiveness of COVID-19 Vaccination in a Regional PopulationSemantic proximity Read

Optimising health and economic impacts of COVID-19 vaccine prioritisation strategies in the WHO European RegionSemantic proximity Read

Comparison of vaccine effectiveness against the Omicron (B.1.1.529) variant in patients receiving haemodialysisSemantic proximity Read

Cost-effectiveness of routine COVID-19 adult vaccination programmes in EnglandSemantic proximity Read

Long Term Vaccination Strategies to Mitigate the Global Impact of SARS-CoV-2 Transmission: A Modelling StudySemantic proximity Read

Comparative COVID-19 Vaccines Effectiveness in Preventing Infections, Hospitalizations, and Deaths with SARS-CoV-2 BA.5 and Ba.2 Omicron Lineages: A Case-Case and Cohort Study Using Electronic Health Records in PortugalSemantic proximity Read

Determinants of passive antibody efficacy in SARS-CoV-2 infectionSemantic proximity Read

Mathematical models of COVID-19 vaccination in high-income countries: A systematic reviewSemantic proximity Read

COVID-19 Vaccine effectiveness against symptomatic infection and hospitalization in Belgium, July 2021-APRIL 2022Semantic proximity Read

Estimating long-term vaccine effectiveness against SARS-CoV-2 variants: a model-based approachSemantic proximity Read